Top Health-care stocks:
Health-care shares were fairly flat in pre-market trade
In health-care stocks news, biopharmaceutical company Intercept
Pharmaceuticals Inc. (
) has been upgraded by analysts at Leerink Swann to an outperform
rating from market perform.
The firm also boosted its price target on the stock to $445 from
$270 a share, which represents a potential upside of 88% from its
Shares of ICPT have soared nearly 58% to $373.84 in Tuesday's
, moving within a 52-week range of $42.41 - $497. The gains follow
earnings and a pipeline update issued Monday night.
And, Opko Health (
) shares edged higher in Tuesday's pre-market session, after the
biopharmaceutical-and-diagnostics company late Monday reported a
narrower-than-expected Q2 loss and released successful top-line
results from the first pivotal phase 3 trial of its Rayaldee
treatment for secondary hyperparathyroidism in patients with stage
3 or 4 chronic kidney disease and vitamin D insufficiency.
OPK was up 2.9% at $9.63 in recent pre-market trading, in a
52-week range of $7.32 to $12.95.
Finally, Insys Therapeutics (
) is up after the company said it submitted a New Drug Application
to the U.S. FDA for its proprietary Dronabinol Oral Solution for
anorexia associated with weight loss in patients with AIDS; and
nausea and vomiting associated with cancer chemotherapy in patients
who have failed to respond adequately to conventional antiemetic